Black Hawk Acquisition Corporation
Status: Live Deal
U=S+R/5
R=S
| IPO Proceeds, $M | $69.00M |
|---|---|
| IPO Date | Mar 21, 2024 |
| CEO | Kent Louis Kaufman |
| Left Lead | D. Boral Capital |
| IPO Cash in Trust | 100.5% |
| SPAC Tenor | 15 + (2*3) |
| IPO Sector | General ▶ |
| IPO Geography | Global |
| Target Company | Vesicor Therapeutics |
| Deal Announced | Apr 28, 2025 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | TBD |
BKHA
BKHAU
BKHAR
| Price | $10.55 |
|---|---|
| Last closing price | $10.54 |
| H/L, today | $10.55 / $10.63 |
| Volume, today | 202 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.